Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study of the Efficacy and Safety of Vamifeport in Adult Subjects With HFE-related Hereditary Hemochromatosis (FERROCLEAR Study)

This is a phase 2, multicenter, randomized, placebo-controlled, double-blind, parallel-group, proof-of-concept study to assess vamifeport in adult participants…

Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis

CSL BehringNCT07332091